3Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin : aprotein secreted by visceral fat that mimics the effects ofinsulin [ J ]. Science,2005,307 ( 5 708 ) :426 - 430.
4World Health Organization. Obesity: Preventing andManaging the Global Epidemic : Report a WHO consul-tation[ R]. WoAd Health Organ Tech Rep Ser, 2000,894 : 1 - 253.
5Haider DG, Schindler K, Schaller G, et al. Increasedplasnm visfatin concentrations in morbidly obese sub-jects are reduced after gastric banding[ J ]. J Clin Endo-crinol Metab,2006,91 (4) :1 578 - 1 581.
6Varma V, Yao-Borengasser A, Rasouli N, et al. Humanvisfatin expression:relationship to insulin sensitivity,in-tramyocellular lipids, and inflammation[ J]. J Clin En-docrinol Metab,2007,92 (2) : 666 - 672.
7Pagano C, Pilon C, Olivieri M, et al. Reduced plasmavisfatilv/pre-B cell colony-enhancing factor in obesity isnot related to insulin resistance in humans[J].J ClinEndoerinol Metab,2006,91 (8) :3 165 - 3 170.
8Jian WX, Luo TH, Gu YY, et al. The Visfatln gene isassociated with glucose and lipid metabolism in a Chi-nese population [ J ]. Diabet Med, 2006,23 ( 9 ) : 967 -973.
1Krug AW, Stelzner L, Rao AD, et al. Effect of low dose mineralocorti- cold receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males [ J 3 . Metabolism: Clinical and Experimental, 2013, 62 (3): 386-391.
2Wang J, Rong X, Li W, et al. Rhodiola crenulata root amelii)mtes de1 rangements of glucose and lipid metabolism in a rat model of the metabol[ ic syndrome and type 2 diabetes [ J~ . Journal of Ethnopharmaeologyt 2012, 142 (3): 782-788. [.
3Si M, Yan Y, Tang L, et al. A novel indole derivative compound GY3 improves glucose and lipid metabolism via activation of AMP - activated protein kinase pathway [ J 3 . European Journal of Pharmacology, 2013, 698 (1/3): 480-488.
4Lee SH, Min KH, Han JS, et al. Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ -db/db mice, a model of type 2 diabetes mellitus ~ J 1 . Food and Chemical Toxicology, 2012, 50 (3/4): 575-582.
